We are live on ! Find out more
AWM

Apollon Wealth Management Portfolio holdings

AUM $8.23B
1-Year Est. Return 30.88%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+30.88%
3 Year Est. Return
+87.48%
5 Year Est. Return
+103.54%
10 Year Est. Return
AUM
$2.89B
AUM Growth
+$903M
Cap. Flow
+$663M
Cap. Flow %
22.91%
Top 10 Hldgs %
21.16%
Holding
1,121
New
215
Increased
612
Reduced
197
Closed
52

Sector Composition

Rank Sector Weight
1 Technology 15.4%
2 Financials 7.48%
3 Healthcare 5.75%
4 Consumer Discretionary 5.47%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ED icon
651
Consolidated Edison
ED
$39.8B
$499K 0.02%
5,487
-4
-0.1% -$357
ZBH icon
652
Zimmer Biomet
ZBH
$18.4B
$497K 0.02%
4,085
+1,898
+87% +$212K
IT icon
653
Gartner
IT
$11.7B
$497K 0.02%
1,101
+225
+26% +$89.9K
FDS icon
654
Factset
FDS
$10.2B
$496K 0.02%
1,039
+560
+117% +$252K
FEZ icon
655
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.55B
$492K 0.02%
10,300
SAN icon
656
Banco Santander
SAN
$210B
$492K 0.02%
118,939
+60,233
+103% +$236K
MGM icon
657
MGM Resorts International
MGM
$11.2B
$492K 0.02%
+11,018
New +$432K
FPE icon
658
First Trust Preferred Securities and Income ETF
FPE
$6.36B
$492K 0.02%
29,198
-55,379
-65% -$893K
SAP icon
659
SAP
SAP
$238B
$492K 0.02%
+3,182
New +$460K
TDG icon
660
TransDigm Group
TDG
$67.7B
$492K 0.02%
486
+122
+34% +$113K
PFL
661
PIMCO Income Strategy Fund
PFL
$388M
$491K 0.02%
58,213
PTCT icon
662
PTC Therapeutics
PTCT
$6.12B
$487K 0.02%
17,682
+4
+0% +$91
APTV icon
663
Aptiv
APTV
$10.3B
$486K 0.02%
5,414
-637
-11% -$54.8K
EMN icon
664
Eastman Chemical
EMN
$8.42B
$485K 0.02%
+5,397
New +$430K
CSWC icon
665
Capital Southwest
CSWC
$1.6B
$484K 0.02%
20,429
+1,139
+6% +$25.4K
RITM icon
666
Rithm Capital
RITM
$5.69B
$483K 0.02%
+45,260
New +$450K
BKR icon
667
Baker Hughes
BKR
$61.1B
$481K 0.02%
14,082
+3,295
+31% +$112K
GEHC icon
668
GE HealthCare
GEHC
$32.4B
$481K 0.02%
6,224
+1,847
+42% +$129K
BR icon
669
Broadridge
BR
$19B
$480K 0.02%
2,335
+118
+5% +$21.8K
SPMB icon
670
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7B
$479K 0.02%
21,713
+6,996
+48% +$147K
CPA icon
671
Copa Holdings
CPA
$5.8B
$478K 0.02%
4,496
-266
-6% -$24.3K
MLKN icon
672
MillerKnoll
MLKN
$1.67B
$475K 0.02%
+17,793
New +$454K
FDL icon
673
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.82B
$473K 0.02%
13,179
CTRA
674
DELISTED
Coterra Energy
CTRA
$472K 0.02%
18,499
+5,099
+38% +$137K
EXC icon
675
Exelon
EXC
$47B
$471K 0.02%
13,121
+5,322
+68% +$205K

Similar funds

Apollon Wealth Management's Q4 2023 Portfolio in Review

As of Q4 2023, Apollon Wealth Management held 1,121 positions worth $2.89B, up 45% from $1.99B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Apollon Wealth Management deployed $663M of net new capital in Q4 2023, opening 215 new positions and adding to 612 existing holdings. Its largest new stake was Avantis Emerging Markets Equity ETF: 238,063 shares worth $13.4M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $67.9M trimmed.

  • Apollon Wealth Management's largest Q4 2023 buy was Avantis Emerging Markets Equity ETF: 238,063 shares worth $13.4M.
  • Apollon Wealth Management added most to iShares Core US Aggregate Bond ETF in Q4 2023, an estimated $38.1M increase.
  • Apollon Wealth Management's biggest Q4 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $67.9M.
  • Apollon Wealth Management fully exited Activision Blizzard in Q4 2023, selling an estimated $1.45M.
  • Apollon Wealth Management's ten largest holdings make up 21% of its $2.89B portfolio in Q4 2023.
  • Apollon Wealth Management opened 215 new positions and closed 52 in Q4 2023.
  • Apollon Wealth Management's portfolio value rose 45% quarter-over-quarter to $2.89B.

Based on Apollon Wealth Management's 13F filing for Q4 2023, filed 6 Feb 2024.